Insulin Market Revenue 2024 to 2034
Insulin Market Revenue 2024 to 2034
The insulin market size is anticipated to grow from USD 30.76 billion in 2025 to USD 44.54 billion by 2034, with a compound annual growth rate (CAGR) of 4.2% during the forecast period from 2025 to 2034.
Report ID: 10066
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 29.52 Bn
Forecast Year,
USD USD 44.54 Bn
CAGR, 2025 -
4.2%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Insulin Market Size Analysis
Insulin Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rapid-Acting (Fastest growing) | 5.90 | 6.19 | 6.49 | 6.80 | 7.13 | 7.47 | 7.83 | 8.20 | 8.60 | 9.01 | 9.44 |
| Short-Acting | 5.31 | 5.52 | 5.74 | 5.96 | 6.19 | 6.44 | 6.69 | 6.95 | 7.22 | 7.50 | 7.79 |
| Intermediate-Acting | 3.54 | 3.68 | 3.82 | 3.97 | 4.12 | 4.28 | 4.44 | 4.61 | 4.79 | 4.98 | 5.17 |
| Premixed Long-Acting (Dominated) | 14.76 | 15.37 | 16.01 | 16.67 | 17.36 | 18.08 | 18.83 | 19.60 | 20.42 | 21.26 | 22.14 |
Insulin Market Size By Source 2024 to 2034 (USD )
| Source | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Insulin | 10.33 | 10.75 | 11.19 | 11.64 | 12.11 | 12.60 | 13.11 | 13.64 | 14.20 | 14.77 | 15.37 |
| Insulin Analog (Dominated) | 19.19 | 20.01 | 20.86 | 21.76 | 22.69 | 23.66 | 24.68 | 25.73 | 26.83 | 27.98 | 29.17 |
Insulin Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies (Fastest Growing) | 7.38 | 7.72 | 8.08 | 8.45 | 8.84 | 9.25 | 9.67 | 10.12 | 10.59 | 11.07 | 11.58 |
| Retail Pharmacies (Dominated) | 17.71 | 18.42 | 19.15 | 19.92 | 20.71 | 21.54 | 22.40 | 23.29 | 24.22 | 25.19 | 26.19 |
| Online Pharmacies | 4.43 | 4.62 | 4.82 | 5.03 | 5.25 | 5.48 | 5.71 | 5.96 | 6.22 | 6.49 | 6.77 |
Insulin Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Type 1 Diabetes | 5.31 | 5.55 | 5.79 | 6.04 | 6.31 | 6.58 | 6.87 | 7.17 | 7.48 | 7.81 | 8.15 |
| Type 2 Diabetes (Dominated) | 21.25 | 22.12 | 23.02 | 23.97 | 24.94 | 25.96 | 27.03 | 28.13 | 29.28 | 30.47 | 31.71 |
| Gestational Diabetes (Significantly growing) | 2.95 | 3.09 | 3.24 | 3.39 | 3.55 | 3.72 | 3.89 | 4.07 | 4.27 | 4.47 | 4.68 |
Insulin Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11.22 | 11.68 | 12.16 | 12.66 | 13.18 | 13.72 | 14.29 | 14.88 | 15.49 | 16.13 | 16.79 |
| Europe | 7.97 | 8.30 | 8.64 | 9.00 | 9.37 | 9.75 | 10.16 | 10.57 | 11.01 | 11.47 | 11.94 |
| Asia-Pacific | 6.49 | 6.78 | 7.08 | 7.39 | 7.71 | 8.05 | 8.40 | 8.77 | 9.16 | 9.56 | 9.98 |
| Latin America | 2.07 | 2.16 | 2.25 | 2.35 | 2.45 | 2.56 | 2.67 | 2.78 | 2.90 | 3.03 | 3.16 |
| Middle East & Africa | 1.77 | 1.85 | 1.92 | 2.00 | 2.09 | 2.18 | 2.27 | 2.36 | 2.46 | 2.56 | 2.67 |
Insulin Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
